← FDA DRUG APPROVALS
FDA ANDA · ANDA214894
DIFLUPREDNATE OPHTHALMIC EMULSION
difluprednate ophthalmic
Sponsor: DR REDDYS
APPLICATION
ANDA214894
TYPE
ANDA
ORIGINAL APPROVAL
2022-11-16
LATEST ACTION
2022-11-16
ROUTE
OPHTHALMIC
DOSAGE FORM
EMULSION
MARKETING STATUS
Prescription
Products
DIFLUPREDNATEPrescription
DIFLUPREDNATE 0.05% · EMULSION · OPHTHALMIC
Approval history
2022-11-16UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.